Stock Events

Stock Events

Creative Medical Technology 

$1.0800
28
+$0.00+0% 11:18 Today

Statistics

Day High
1.085
Day Low
1.085
52W High
6.25
52W Low
0.62
Volume
10,104
Avg. Volume
-
Mkt Cap
7.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.09
-0.81
-0.52
-0.24
Expected EPS
-0.24
Actual EPS
N/A

Financials

-99,916.67%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
6,000Revenue
-6MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CELZ. It's not an investment recommendation.
Amazon
3
AMZN
Coca-Cola
3
KO
Bitcoin
3
BTC.CRYPTO
Dogecoin
3
DOGE.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap666.13M
MiMedx Group, Inc. specializes in regenerative biomaterials, a field closely related to Creative Medical's focus on regenerative medicine, making them direct competitors in the market for healing and regeneration solutions.
Mesoblast
MESO
Mkt Cap2.25B
Mesoblast Limited focuses on regenerative medicine using its proprietary mesenchymal lineage cell therapy technology, competing in the same space as Creative Medical's regenerative therapies.
Vericel
VCEL
Mkt Cap2.06B
Vericel Corporation produces autologous cell therapies for treating damaged or diseased tissue, which competes with Creative Medical's approach to tissue regeneration and repair.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap11.92M
Brainstorm Cell Therapeutics Inc. works on developing innovative, autologous stem cell therapies for neurodegenerative diseases, overlapping with Creative Medical's interest in regenerative treatments.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics AG is focused on gene editing, a cutting-edge area of biotechnology that competes with Creative Medical's regenerative medicine and cell therapy techniques.
Editas Medicine
EDIT
Mkt Cap496.06M
Editas Medicine, Inc. is involved in gene editing technology, which represents a competitive approach to Creative Medical's focus on regenerative and cell-based therapies.
Intellia Therapeutics
NTLA
Mkt Cap1.79B
Intellia Therapeutics, Inc. specializes in CRISPR/Cas9 gene editing, competing in the innovative treatment space that includes Creative Medical's regenerative medicine efforts.

About

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Show more...
CEO
Timothy Warbington
Employees
4
Country
United States
ISIN
US22529Y4089

Listings

XNAS
US
CELZ
BOATS
BOATS
CELZ.BOATS

0 Comments

Share your thoughts

FAQ

What is Creative Medical Technology stock price today?▼
The current price of CELZ is $1.08 USD — it has increased by +0% in the past 24 hours. Watch Creative Medical Technology stock price performance more closely on the chart.
What is Creative Medical Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Creative Medical Technology stocks are traded under the ticker CELZ.
Is Creative Medical Technology stock price growing?▼
CELZ stock has fallen by -4.42% compared to the previous week, the month change is a -23.94% fall, over the last year Creative Medical Technology has showed a -68.33% decrease.
What is Creative Medical Technology market cap?▼
Today Creative Medical Technology has the market capitalization of 7.12M
When is the next Creative Medical Technology earnings date?▼
Creative Medical Technology is going to release the next earnings report on December 02, 2026.
What were Creative Medical Technology earnings last quarter?▼
CELZ earnings for the last quarter are -0.41 USD per share, whereas the estimation was -0.41 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Creative Medical Technology revenue for the last year?▼
Creative Medical Technology revenue for the last year amounts to 6,000 USD.
What is Creative Medical Technology net income for the last year?▼
CELZ net income for the last year is -6M USD.
How many employees does Creative Medical Technology have?▼
As of September 09, 2026, the company has 4 employees.
In which sector is Creative Medical Technology located?▼
Creative Medical Technology operates in the Health & Wellness sector.
When did Creative Medical Technology complete a stock split?▼
The last stock split for Creative Medical Technology was on June 12, 2023 with a ratio of 1:10.
Where is Creative Medical Technology headquartered?▼
Creative Medical Technology is headquartered in PHOENIX, United States.